T2 Biosystms Stock Net Income
| TTOO Stock | USD 3.72 0.07 1.92% |
T2 Biosystms fundamentals help investors to digest information that contributes to T2 Biosystms' financial success or failures. It also enables traders to predict the movement of TTOO Stock. The fundamental analysis module provides a way to measure T2 Biosystms' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to T2 Biosystms stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | -50.1 M | -52.6 M | |
| Net Loss | -49.8 M | -52.3 M | |
| Net Loss | -56.4 M | -59.2 M | |
| Net Loss | (19.19) | (20.15) | |
| Net Income Per E B T | 1.02 | 1.17 |
TTOO | Net Income |
T2 Biosystms Company Net Income Analysis
T2 Biosystms' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current T2 Biosystms Net Income | (50.08 M) |
Most of T2 Biosystms' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, T2 Biosystms is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
TTOO Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for T2 Biosystms is extremely important. It helps to project a fair market value of TTOO Stock properly, considering its historical fundamentals such as Net Income. Since T2 Biosystms' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of T2 Biosystms' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of T2 Biosystms' interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
TTOO Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, T2 Biosystms reported net income of (50.08 Million). This is 114.67% lower than that of the Biotechnology sector and 128.93% lower than that of the Health Care industry. The net income for all United States stocks is 108.77% higher than that of the company.
TTOO Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses T2 Biosystms' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of T2 Biosystms could also be used in its relative valuation, which is a method of valuing T2 Biosystms by comparing valuation metrics of similar companies.T2 Biosystms is currently under evaluation in net income category among related companies.
T2 Biosystms Institutional Holders
Institutional Holdings refers to the ownership stake in T2 Biosystms that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of T2 Biosystms' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing T2 Biosystms' value.| Shares | Royal Bank Of Canada | 2023-12-31 | 1.3 K | Cwm, Llc Duplicate | 2023-12-31 | 310 | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 120 | Signature Resources Capital Management, Llc | 2023-12-31 | 90.0 | Wells Fargo & Co | 2023-12-31 | 22.0 | Jjj Advisors Inc | 2023-12-31 | 9.0 | U.s. Bancorp | 2023-12-31 | 3.0 | Focused Wealth Strategies, Inc. | 2023-12-31 | 3.0 | Bank Of America Corp | 2023-12-31 | 2.0 | Susquehanna International Group, Llp | 2023-12-31 | 55 K | Vanguard Group Inc | 2023-12-31 | 45.7 K |
TTOO Fundamentals
| Return On Equity | -6.22 | ||||
| Return On Asset | -0.85 | ||||
| Operating Margin | (5.55) % | ||||
| Current Valuation | 53.93 M | ||||
| Shares Outstanding | 8.79 M | ||||
| Shares Owned By Insiders | 4.23 % | ||||
| Shares Owned By Institutions | 49.39 % | ||||
| Number Of Shares Shorted | 374.49 K | ||||
| Price To Earning | (2.04) X | ||||
| Price To Book | 14.50 X | ||||
| Price To Sales | 2.41 X | ||||
| Revenue | 7.19 M | ||||
| Gross Profit | (24.77 M) | ||||
| EBITDA | (46.29 M) | ||||
| Net Income | (50.08 M) | ||||
| Cash And Equivalents | 13.21 M | ||||
| Cash Per Share | 1.87 X | ||||
| Total Debt | 49.5 M | ||||
| Debt To Equity | 6.64 % | ||||
| Current Ratio | 1.87 X | ||||
| Book Value Per Share | (6.91) X | ||||
| Cash Flow From Operations | (48.2 M) | ||||
| Short Ratio | 1.59 X | ||||
| Earnings Per Share | (19.19) X | ||||
| Target Price | 3.0 | ||||
| Number Of Employees | 113 | ||||
| Beta | 0.099 | ||||
| Market Capitalization | 32.93 M | ||||
| Total Asset | 34.8 M | ||||
| Retained Earnings | (584.3 M) | ||||
| Working Capital | (30.96 M) | ||||
| Current Asset | 77.78 M | ||||
| Current Liabilities | 18.54 M | ||||
| Net Asset | 34.8 M |
About T2 Biosystms Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze T2 Biosystms's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of T2 Biosystms using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of T2 Biosystms based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards T2 Biosystms in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, T2 Biosystms' short interest history, or implied volatility extrapolated from T2 Biosystms options trading.
Currently Active Assets on Macroaxis
| LAAC | Lithium Americas Corp | |
| F | Ford Motor | |
| CHPT | ChargePoint Holdings | |
| AXL | American Axle Manufacturing | |
| ICLN | iShares Global Clean |
Check out T2 Biosystms Piotroski F Score and T2 Biosystms Altman Z Score analysis. To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for TTOO Stock analysis
When running T2 Biosystms' price analysis, check to measure T2 Biosystms' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy T2 Biosystms is operating at the current time. Most of T2 Biosystms' value examination focuses on studying past and present price action to predict the probability of T2 Biosystms' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move T2 Biosystms' price. Additionally, you may evaluate how the addition of T2 Biosystms to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is T2 Biosystms' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (19.19) | Revenue Per Share 2.756 | Quarterly Revenue Growth (0.69) | Return On Assets (0.85) | Return On Equity (6.22) |
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.